All News #Library
Biotech
Tris Pharma Presents Encore Phase 3 Data On Acute Pain Treatment
08 Apr 2026 //
GLOBENEWSWIRE
Tris Pharma To Unveil Phase 3 Cebranopadol Data For Acute Pain
26 Feb 2026 //
GLOBENEWSWIRE
Tris Pharma Spotlights Dual NOP-MOP Promise for Pain Treatment
08 Jan 2026 //
GLOBENEWSWIRE
Tris Pharma Publishes Review on Acute Pain Treatment Gaps
16 Oct 2025 //
BUSINESSWIRE
Tris Pharma Show Dual-NOP/MOP Agonist, Ph 3 Pain Data at PAINWeek
28 Aug 2025 //
BUSINESSWIRE

Market Place
Sourcing Support